Symposia: Aggressive Lymphomas: Cellular Therapies
	
	
	Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Adult, Translational Research, Lymphomas, Non-Hodgkin lymphoma, Drug development, Clinical Research, B Cell lymphoma, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Diseases, Real-world evidence, Aggressive lymphoma, Treatment Considerations, Biological therapies, Lymphoid Malignancies, Study Population, Human
	Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Adult, Translational Research, Lymphomas, Non-Hodgkin lymphoma, Drug development, Clinical Research, B Cell lymphoma, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Diseases, Real-world evidence, Aggressive lymphoma, Treatment Considerations, Biological therapies, Lymphoid Malignancies, Study Population, Human
Saturday, December 7, 2024: 9:30 AM-11:00 AM
	Pacific Ballroom Salons 18-19 
		(Marriott Marquis San Diego Marina)
	
	
	
	
	   
	
	
			
		Moderators:
			
				
				
					
						
						
						
							Elise A. Chong, MD, ARRAY(0xdcd2fc4)
						
					
					
				
					
						 and 
						
						
							Andrew P Jallouk, MD, PhD, Vanderbilt University Medical Center
						
					
					
				
			
 
			
			Disclosures:
			
			
				
			
				
			
			Chong: AbbVie: Consultancy, Research Funding; Genentech/Roche: Research Funding; CARGO: Research Funding; Nurix: Research Funding; AstraZeneca: Consultancy, Research Funding; Beigene: Consultancy; Genmab: Consultancy, Research Funding. Jallouk: Kite/Gilead: Consultancy, Research Funding; Allogene Therapeutics: Research Funding. 
			 
		9:30 AM
	
	
9:45 AM
	
	
10:00 AM
	
	
10:15 AM
	
	
10:30 AM
	
	
10:45 AM
	
	
	
	
	See more of: Oral and Poster Abstracts
	
	
	
	
	*signifies non-member of ASH
					
	
	
 denotes an abstract that is clinically relevant.
 denotes that this is a recommended PHD Trainee Session.